Dyadic and Medytox to co-develop Covid-19 variant fighting vaccines

If the Dyadic and Medytox co-developed C1-manufactured Covid-19 vaccines/boosters are successful, they can be used to fight against a minimum of two current and future Covid-19 variants. Credit: Macau Photo Agency/Unsplash.